Position in LIVN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$6,932,317
+$1,289,588 QoQ
Shares Held
84,304
-5.0% QoQ
Ownership
0.153%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#74
of 303 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LIVN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026NORDEA INVESTMENT MANAGEMENT AB holds $936,162,906 across 18 Medical Devices names. LIVN ranks #10 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
837,203 | $263,584,991 | |
| 2 | EW |
Edwards Lifesciences Corp
|
1,629,844 | $147,435,686 | |
| 3 | BSX |
Boston Scientific Corp
|
2,610,440 | $111,413,577 | |
| 4 | MDT |
Medtronic plc
|
1,314,949 | $102,868,458 | |
| 5 | GEHC |
GE HealthCare Technologies Inc.
|
1,503,738 | $96,254,268 | |
| 6 | PODD |
Insulet Corp
|
618,174 | $94,116,990 | |
| 7 | ABT |
Abbott Laboratories
|
714,759 | $64,857,230 | |
| 8 | DXCM |
Dexcom Inc
|
288,480 | $19,429,127 |
All Filings in LIVN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,932,317 | 84,304 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $5,642,729 | 88,778 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,676,634 | 92,258 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $5,511,056 | 105,213 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $4,648,944 | 103,264 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $3,961,859 | 100,862 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $3,182,004 | 68,711 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $2,954,900 | 56,241 | Shares | Sole | 2024-11-05 | |
| No filing history on record for this holder in this stock. | ||||||